Donate
Sign-in Local Events
Professionals



  1. FDA announces Warfarin recall for patients/providers
ACC 2011: Rheos Trial
  • Updated:Apr 5,2011
ACC11_Header2
Rheos Trial
Baroreflex Activation Therapy Sustainably Lowers Blood Pressure in Patients with Resistant Hypertension: Results from the Rheos Pivotal Trial
acc11_RheosPivotal_imageJohn D. Bisognano, MD, PhD, University of Rochester Medical Center, Rochester, NY, University of Chicago, Chicago, IL






ACC11_AdBanner
 esc11_membership_iconesc11_mgam_iconesc11_ytc_iconss11_logo_icon
Join usSpread the word Become an advocateRegister today
esc11_pon_icon esc11_twitter_icon esc11_facebook_iconesc11_youtube_icon 
Join the conversation Follow @AHAScience Like us on Facebook Tune in
esc11_cvdaily_iconesc11_circ_ipad_iconesc11_stats_icon 
Subscribe nowCirculation for the iPadLearn more 

     

ACC 2011: Navigation
Science News from ACC 2011 - Home
Sunday, April 3
PARTNERPARTNER Cohort B
 
Monday, April 4
PRECOMBAT
EVEREST II
STICH
STICH Viability
RAPS		ISAR-CABG
RIVAL
RESOLUTE US
PLATINUM
REMEDIAL II
 
Tuesday, April 5
MAGELLAN
OSCAR
NAGOYA HEART Study
PROTECTION-AMI
EXCELLENT
 		TARGET Study
Rheos Trial
PROACT
AF Clinic
Danish Heart Failure Study
 
Science News Videos
Click on the link below to view complete video coverage from ACC 2011.  Plus, search all AHA/ASA Science news video archives.

acc11_sn_youtube2_button
 



 
Emerging Science Series
Emerging Science with Dates
Scientific Sessions scientificsessions_logo_2013_webheader

Scientific Sessions 2013
Scientific Sessions is the leading cardiovascular meeting in the country with over 17,000 professionals attending annually, and over 22,000 total attendees, as reported by the Healthcare Convention and Exhibitor’s Association. 

Dallas Convention Center
Dallas, Texas
Nov. 16–20, 2013